Direct injection of monoclonal antibodies isn’t always the best treatment option, especially when battling autoimmune diseases or other conditions that require longterm therapy. Long-term sustained systemic delivery may be achieved through implanting antibody-producing cells encapsulated in a biocompatible material.
Encapsulated antibody-producing cells for long-term passive immunotherapy
Pelegrin, M.; Noel, D.; Saller, R.; Salmons, B.; Piechaczyk, M.
1999
Biopharm-the Applied Technologies of Biopharmaceutical Development
1999-10 / vol 12 / pages 32-+
Abstract
1040-8304
Tags
delivery; therapy; lymphoma; monoclonal-antibody